Addex Therapeutics Ltd
SIX:ADXN
Addex Therapeutics Ltd
SIX:ADXN
Price:
0.071 CHF
-3.79%
Market Closed
Updated:
May 15, 2024
Addex Therapeutics Ltd
EPS (Diluted)
|
Addex Therapeutics Ltd
EPS (Diluted) Peer Comparison
Comparables:
ADCT
ACIU
CRSP
BSLN
IDIA
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Addex Therapeutics Ltd
SIX:ADXN
|
EPS (Diluted)
CHf0
|
CAGR 3-Years
34%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
EPS (Diluted)
-$2
|
CAGR 3-Years
3%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
EPS (Diluted)
CHf0
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
EPS (Diluted)
-$2
|
CAGR 3-Years
20%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
EPS (Diluted)
CHf0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Idorsia Ltd
SIX:IDIA
|
EPS (Diluted)
-CHf4
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-108%
|
CAGR 10-Years
N/A
|
See Also
What is Addex Therapeutics Ltd's EPS (Diluted)?
EPS (Diluted)
-0.1
CHF
-0.1
CHF
Based on the financial report for Dec 31, 2023, Addex Therapeutics Ltd's EPS (Diluted) amounts to -0.1 CHF.
What is Addex Therapeutics Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-15%
-15%
Over the last year, the EPS (Diluted) growth was 70%. The average annual EPS (Diluted) growth rates for Addex Therapeutics Ltd have been 34% over the past three years , -15% over the past five years .
You don't have any saved screeners yet
